# Triumeq

NDC: 49702-231
Generic name: abacavir sulfate, dolutegravir sodium, lamivudine
Labeler / Manufacturer: ViiV Healthcare Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20140822

FDA application: NDA205551

## Active ingredients

- ABACAVIR SULFATE: 600 mg/1
- DOLUTEGRAVIR SODIUM: 50 mg/1
- LAMIVUDINE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49702-231"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49702-231
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2997739a-aa91-42aa-a206-a70e2db7b84f